Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(25 sites)
United States
Barrow Neurological Institute, Phoenix, Arizona Banner Sun Health Research Institute, Sun City, Arizona UC Los Angeles, Los Angeles, California Esperanza Clinical, Murrieta, California Sutter Health, San Francisco, California Galiz Research, Hialeah, Florida UF College of Medicine - Jacksonville, Jacksonville, Florida K2 Medical Research, Lady Lake, Florida K2 Medical Research, Maitland, Florida ClinCloud Research, Melbourne, Florida Miami Jewish Health Systems, Miami, Florida The Roskamp Institute, Sarasota, Florida Charter Research, Winter Park, Florida Alzheimer's Disease Center, Braintree, Massachusetts Headlands Research, Plymouth, Massachusetts Be Well Clinical Studies, Lincoln, Nebraska Darthmouth-Hitchcock Medical Center, Lebanon, New Hampshire Velocity Clinical Research, East Syracuse, New York Ichor Research, Syracuse, New York American Carolina Clinical Research LLC, Charlotte, North Carolina Insight Clinical Trials LLC, Beachwood, Ohio Valley Medical Research, Centerville, Ohio Baylor Research Institute, Dallas, Texas Sante Clinical Research, Kerrville, Texas Be Well Clinical Studies, Round Rock, Texas